Contraceptives Market Size to Exceed USD 47.14 Bn by 2032

The Contraceptives Market, estimated at USD 19.79 Bn in 2025, is expected to exhibit a CAGR of 13.2% and reach USD 47.14 Bn by 2032.

The market growth is driven by increasing demand for innovative and effective drugs across diverse therapeutic areas. Advances in drug discovery, biopharmaceuticals, and digital technologies are improving treatment outcomes and operational efficiency. Supportive regulations, rising R&D investments, and a strong focus on patient-centric care are creating new opportunities for pharmaceutical companies.

Contraceptive pills which is also known as birth control pills, are used to prevent pregnancy. They contain synthetic versions of the sex hormones estrogen and progesterone which prevent ovulation and fertilization. Some common benefits of contraceptive pills include light and regular periods, reduction in menstrual cramps and prevention of certain cancers.

Global Contraceptive Market- Drivers

Growing awareness about family planning and women healthcare is driving the demand for contraceptive pills.One of the major market drivers for the global contraceptive pills market is the growing awareness among people about the importance of family planning and  healthcare of the women. With improving literacy rates and access to information globally, more people are understanding the medical and socio-economic benefits of properly spacing out pregnancies and family size. This has significantly increased the acceptability and demand for modern contraceptive methods like contraceptive pills. Several government initiatives and nongovernmental organization (NGO) programs in developing regions are focused on educating people about reproductive health and rights. This is positively impacting the contraceptive pills market size. Growing women workforce participation worldwide has also boosted the need for reliable yet user-friendly birth control solutions like pills.

Global Contraceptive Market - Restraints

Side effects that are associated with pill intake  is a major obstacle in the growth path of global contraceptive market. One of the major market restraints for contraceptive pills is the potential side effects that are associated with their usage, especially in the initial months. Common temporary side effects include nausea, breast tenderness, headache, and changes in menstrual bleeding patterns. These are relatively minor but can be uncomfortable for some women. In rare cases, serious health issues like blood clots, heart attacks or stroke have also been associated with combined oral contraceptive pill intake. While advanced pills have much lower health risks, negative publicity around side effects does impact uptake to some extent. This is a major consideration for women looking for alternative methods without systemic effects.

Counterbalance: The evolving landscape of digital health solutions provides opportunities for remote monitoring and support, thereby enabling timely intervention and management of side effects. By fostering a collaborative approach between healthcare providers, researchers, and women themselves, the contraceptive industry can navigate the challenges posed by side effects, ultimately bolstering confidence in pill-based contraception and promoting broader access to safe and effective family planning methods.

Global Contraceptive Market- Opportunities

Contraceptive pills are one of the most effective methods for preventing pregnancies when taken as directed. When used perfectly, their effectiveness rate is over 99%. Even with typical use, contraceptive pills are over 91% effective which is significantly higher than other traditional methods. This high efficacy makes them a preferred first-line contraceptive choice for millions of women. Their highly effective nature has ensured continued and widespread use over decades. The assurance of pregnancy protection has helped contraceptive pills maintain their leading position in the global contraception market. Various clinical studies and real-world usage data have validated their high contraceptive performance which sustains the demand.

Global Contraceptive Market Segmentation:

Global contraceptive market report is segmented into type, route of administration, age group, distribution channel, and region

Based on type, the market is segmented into combination contraceptives (monophasic pills, multiphasic pills and extended-cycle pills), hormonal contraceptive (progestin-only pills), emergency contraceptives (levonorgestrel-based and ulipristal acetate-based). Out of which combination contraceptives, specifically monophasic pills, are among the dominant types of contraception that are utilized globally due to their effectiveness and ease of use. Monophasic pills contain a fixed dose of estrogen and progestin throughout the entire pill pack, providing a consistent hormonal balance that effectively suppresses ovulation and thickens cervical mucus to inhibit sperm entry into the uterus. This consistency simplifies adherence for users, as they only need to remember to take one type of pill each day. Multiphasic pills offer varying hormone levels throughout the menstrual cycle, mimicking the natural hormonal fluctuations more closely.

Based on route of administration, the market is segmented into oral, injectable, intrauterine, vaginal and others (patches, etc.). Out of which, the oral segment is expected to hold a dominant position in the global contraceptive market during the forecast period. Firstly, oral contraceptives are widely recognized for their convenience and ease of use. They offer a non-invasive method of administration that can be self-administered at home without the need for medical supervision. This accessibility makes oral contraceptives particularly appealing to a broad range of users, including those who may feel uncomfortable with other routes of administration, such as injections or intrauterine devices. The oral route allows for precise dosing and consistent hormone delivery, thus ensuring optimal contraceptive efficacy.

Based on age group, the market is segmented into adolescents and adults. Out of which, the adolescents segment is expected to hold a dominant position in the global contraceptive market during the forecast period, and this is due  to the increasing awareness and education about reproductive health and family planning, more adolescents are seeking access to contraception to prevent unintended pregnancies. Adolescents are often at a stage in their lives where they are exploring relationships and becoming sexually active, thereby making contraception a priority for this demographic. Furthermore, adolescents may face unique challenges and barriers to accessing contraception, such as stigma, lack of knowledge, or concerns about confidentiality.

Based on distribution channel, the market is segmented into online pharmacies, hospital pharmacies and retail pharmacies.Online pharmacies segment are expected to emerge as the dominant distribution channel in the global contraceptive market due to several compelling reasons. Firstly, the convenience and accessibility that are offered by online pharmacies cater to the evolving preferences of consumers, especially in the digital age. With the proliferation of smartphones and internet connectivity, individuals, including those seeking contraceptives, increasingly prefer the ease of purchasing products online from the comfort of their homes. This convenience is particularly advantageous for individuals who may face challenges accessing brick-and-mortar pharmacies due to geographical barriers, transportation limitations, or time constraints.

Browse 44 Market Data Tables and 37 Figures spread through 180 Pages and in-depth TOC on Global Contraceptive Market, By Type Combination Contraceptives (Monophasic pills, Multiphasic pills and Extended-cycle pills), Hormonal Contraceptive (Progestin-Only Pills), Emergency Contraceptives (Levonorgestrel-based and Ulipristal acetate-based), By Route of Administration ( Oral, Injectable, Intrauterine, Vaginal and Others (Patches, etc.)), By Age Group (Adolescents and Adults), By Distribution Channel (Online Pharmacies, Hospital Pharmacies and Retail Pharmacies), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Link: https://www.coherentmarketinsights.com/market-insight/contraceptives-drugs-and-devices-market-365

Key Developments:

• In January 2023, the U.S. Department of Health & Human Services (HHS) and the Departments of Labor and the Treasury (Departments) proposed a rule to strengthen access to birth control coverage under the Affordable Care Act (ACA). Under the ACA, most plans are required to offer coverage of birth control with no out-of-pocket cost.
• In July 2022, Perrigo Company plc, one of the leading global provider of Consumer Self-Care Products, announced that HRA Pharma, a Perrigo company, submitted its application to the U.S. Food and Drug Administration (FDA) for the first-ever over-the-counter (OTC) birth control pill in the United States

Key Takeaways of the Global Contraceptive Market:

• Global contraceptive market is expected to exhibit a CAGR of 13% during the forecast period. For instance, in November 2023, National Health Services (NHS) of England, announced that thousands of women across England will be able to get the contraceptive pill at their local pharmacy from next month, as part of a major expansion of primary care services. The rollout is part of the NHS and government’s primary care access recovery plan.
• Among region, North America is expected to be the dominant region in the global contraceptive market due to increasing government initiatives in the North America region. For instance, in June 2022, the American Medical Association (AMA) announced that it supports removing of the prescription access barrier to contraception and policy adopted by the nation’s physicians and medical students gathered at the AMA Annual Meeting, encourages the U.S. Food and Drug Administration to approve over-the-counter (OTC) access to oral contraceptives without an age restriction.
• Major players operating in the global contraceptive market include Bayer AG, Pfizer Inc., Teva Pharmaceutical Industries, Merck & Co., Janssen Pharmaceutical Companies, Allergan, Piramal Enterprises, Glenmark Pharmaceuticals, Lupin Pharmaceuticals, Mylan Pharmaceuticals, Mithra Pharmaceuticals, Gedeon Richter, HLL Lifecare, Cadila Healthcare, Organon and Other Prominent Players